/Home

Find the right investors for your startup

A free, open database of 26,688 venture funds and 246,835 investors — searchable by stage, sector, and location. No login required.

Tracking the funds you know

Deal radar

Fresh SEC Form D filings our pipeline links to tracked companies and investors — often days before the news breaks. A Form D is the short notice a company or fund must file within 15 days of taking its first money, so it names the amount, the count of investors, and the officers and directors behind the raise.

  • Nov 20, 2026 · Palo Alto, CA · Other Technology

    $85.4Mraised

    BrightAI provides AI hardware, sensors, and drones that add continuous observability to physical infrastructure, using on-device AI models and foundation models trained on telemetry data to predict failures and guide field teams. It serves owners and operators of critical infrastructure, such as water, utilities, and energy companies, to improve productivity, capital efficiency, and safety.

    BrightAI told the SEC it has taken in $85.4M from 10 investors, with the first money in on Dec 5, 2025. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 7 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founder
    Alexander Hawkinson
    On the filing
    Nick Kim·Sand Hill AngelsAlexa von Tobel·Inspired CapitalSamir Kaul·Khosla Ventures
  • Nov 20, 2026 · Greenwich, CT · Other Technology

    $2Mraised

    ennabl (ennabl.AI) is an AI workspace built for insurance agencies, brokerages, wholesalers, and MGAs that reads policy documents and book-of-business data to automate workflows like renewal prep, submission intake, loss-run summarization, ACORD form filling, quote comparison, and proposal generation. It connects to an agency's AMS, CRM, email, and document stores, and produces citable, client-ready deliverables for brokers, agents, producers, and account managers.

    ennabl told the SEC it has taken in $2M from 1 investors, with the first money in on Nov 5, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 6 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founder
    Kabir Syed
    On the filing
    Eric Reiner·Vine VenturesMartha Notaras·Brewer Lane Ventures
  • Nov 20, 2026 · Middletown, DE · Other Technology

    $36Mraised of $55M

    Nimble Precision told the SEC it has taken in $36M of a $55M round from 20 investors, with the first money in on Nov 5, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 2 of the 4 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    On the filing
    Axel Bichara·BaukunstMaryanna Saenko·Future Ventures
  • Nov 20, 2026 · Watertown, MA · Pharmaceuticals

    $68.4Mraised of $150M

    Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

    Matchpoint Therapeutics told the SEC it has taken in $68.4M of a $150M round from 22 investors, with the first money in on Oct 1, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 5 of the 9 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    On the filing
    Brian Matesic·Norwest Venture PartnersKanishka Pothula·Nextech InvestJason P. Hafler·Sanofi VenturesBruce Booth·Atlas VentureJared Cumming·Atlas Venture
  • PathosRule 506(c)

    Nov 19, 2026 · Chicago, IL · Biotechnology

    $237.5Mraised of $300M

    Pathos applies AI, biological modeling, and a large collection of multimodal oncology patient data to develop cancer drugs and accelerate clinical development. It operates the PathOS platform with engines for asset selection, clinical trial execution, and an oncology foundation model.

    Pathos told the SEC it has taken in $237.5M of a $300M round from 13 investors, with the first money in on Aug 21, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 7 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    Eric LefkofkyEric LefkofskyRyan Fukushima
    On the filing
    Eric Lefkofsky·LightbankMohamad Makhzoumi·New Enterprise Associates (NEA)Mike Mauceri·Lightbank
  • PGIM Senior Loan Opportunities (Unlevered) IV, L.P.fund vehicle

    Nov 19, 2026 · Chicago, IL

    PGIM Senior Loan Opportunities (Unlevered) IV, L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise. 4 of the 8 people it names are partners at firms we track.

    On the filing
    Matthew Douglass·DeerpathJeffrey Dickson·DeerpathStephen Collins·Capital D GP SarlMatthew Harvey·Deerpath
  • Nov 19, 2026 · Denver, CO · Other

    $7Mraised

    International Environmental Standards PBC told the SEC it has taken in $7M from 5 investors, with the first money in on Nov 10, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

    Founder
    Chris Romer
    On the filing
    William FoilesJeffrey HarrisThomas B. TyreeCannon TolbertJoshua N. Dunaway
  • Nov 19, 2026 · New York, NY · Other Technology

    $3.1Mraised of $3.6M

    Extend provides a virtual card issuing platform and spend management software that banks can offer to their business customers. The platform modernizes corporate payment infrastructure by enabling flexible card-issuing, expense management, and API-first integration for businesses of all sizes.

    Extend told the SEC it has taken in $3.1M of a $3.6M round from 15 investors, with the first money in on Sep 24, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 3 of the 6 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founders
    Andrew JamisonGuillaume BouvardDannyDaniel Morrow
    On the filing
    Gareth Jones·FinTech CollectiveSolomon Hailu·March Capital PartnersAllen Duan·B Capital Group
  • PGIM Senior Loan Opportunities (Rated Feeder Fund) IV, L.P.fund vehicle

    Nov 19, 2026 · Chicago, IL

    PGIM Senior Loan Opportunities (Rated Feeder Fund) IV, L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise. 4 of the 8 people it names are partners at firms we track.

    On the filing
    Matthew Douglass·DeerpathJeffrey Dickson·DeerpathStephen Collins·Capital D GP SarlMatthew Harvey·Deerpath
  • 26N Hybrid Capital Solutions I-A LPfund vehicle

    Nov 19, 2026 · New York, NY

    26N Hybrid Capital Solutions I-A LP is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise.

    On the filing
    Josh HarrisMark WeinbergBrendan McGovern
  • 26N Hybrid Capital Solutions I LPfund vehicle

    Nov 19, 2026 · New York, NY

    26N Hybrid Capital Solutions I LP is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise.

    On the filing
    Josh HarrisMark WeinbergBrendan McGovern
  • Nov 19, 2026 · Carson City, NV · Biotechnology

    BioVie is a clinical-stage biopharmaceutical company developing bezisterim, a molecule studied for neurodegenerative and inflammatory conditions including Alzheimer's disease, Parkinson's disease, and Long COVID, alongside work on liver disease complications such as ascites. It also researches longevity and epigenetic mechanisms like DNA methylation.

    Biovie told the SEC it reported a new round from 1 investors, with the first money in on Nov 3, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement.

    On the filing
    Cuong DoJoanne Wendy KimSigmund RogichMichael ShermanKameel Farag
  • Nov 19, 2026 · Edison, NJ · Other Technology

    $7Mraised of $7.5M

    Elligint Health provides a connected platform that combines care management, utilization management, and advanced analytics for health plans. The company serves health insurers and medical plans seeking to automate workflows, manage complex member populations, and comply with regulatory requirements.

    Elligint Health, Inc. told the SEC it has taken in $7M of a $7.5M round from 5 investors, with the first money in on May 15, 2026. A Form D is due within 15 days of that first sale, so it routinely surfaces before any announcement. 4 of the 10 people it names are partners at firms we track — investors show up on a Form D as directors, which points to who is behind the round without confirming who led it.

    Founder
    Adam Sabloff
    On the filing
    Lenard Marcus·Edison PartnersGregg Michaelson·Edison PartnersEnrico Picozza·HLM Investment PartnersMichael Ludwig·HLM Investment Partners
  • Nov 19, 2026 · New York, NY

    Managed by Greycroft

    Greycroft is a venture capital firm that partners with founders across multiple industries and geographies, investing in software, sustainability, and consumer brands.

    GC Co-Invest CT, L.P. is a pooled investment vehicle — a fund raising from its own backers, not a startup round. It reported a new raise. All 2 people it names are partners at firms we track.

    On the filing
    Dana Settle·GreycroftIan Sigalow·Greycroft

From public SEC filings; automated matching — filings are facts, interpretations are estimates. See how we read these: the Airtable × Bending Spoons waterfall → The DroneDeploy × Procore waterfall → Every recent raise →

Popular investor lists

Building on the data?

The whole graph as a daily-updated JSON API: firms, companies, rounds, investor→company edges with evidence, funds and SEC filings. Free trial key, no card.

Data API →